Therefore, we further investigated whether K63-ubiquitin overexpression in iHEK-Tau cells treated with AD TauO disrupted mechanisms of protein degradation, including the UPS or the ALS pathways. This evidence concerns the gene MAPT and amyotrophic lateral sclerosis.